NORDEA INVESTMENT MANAGEMENT AB
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1218210
STOCKHOLM, V7
Position in VRTX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$15,148,278
+$3,015,341 QoQ
Shares Held
30,496
+12.2% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#295
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORDEA INVESTMENT MANAGEMENT AB holds $503,679,873 across 20 Biotechnology names. VRTX ranks #5 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
363,479 | $226,643,694 | |
| 2 | RPRX |
Royalty Pharma plc
|
2,576,772 | $144,479,604 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
284,175 | $23,163,103 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
49,943 | $15,786,482 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
30,496 | $15,148,278 | |
| 6 | EXEL |
Exelixis, Inc.
|
210,314 | $11,443,184 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
26,913 | $8,101,620 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
64,964 | $7,963,286 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,148,278 | 30,496 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $12,132,937 | 27,171 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $202,728,535 | 447,169 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $141,415,329 | 361,085 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $10,912,742 | 24,512 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $11,371,452 | 23,455 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $137,896,156 | 342,429 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $133,333,784 | 286,690 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $165,568,309 | 353,235 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $138,557,356 | 331,469 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $130,746,370 | 321,331 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $107,824,437 | 310,072 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $101,680,171 | 288,938 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $84,509,965 | 268,226 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $86,449,180 | 299,360 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $78,975,219 | 272,761 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $70,514,566 | 250,238 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $70,384,652 | 269,704 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $58,631,882 | 266,994 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $43,022,261 | 237,181 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $42,869,965 | 212,617 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $41,371,912 | 192,526 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $32,857,168 | 139,025 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $29,008,808 | 106,603 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $52,253,476 | 179,992 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $14,267,006 | 59,958 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||